Growth hormone deficiency affects approximately 1 in 3,500 children and 1 in 10,000 adults, causing distinct symptoms that vary significantly by age group. In children, the primary symptoms include short stature (growing less than 2 inches per year after age 2), delayed puberty, increased body fat around the waist, and a younger facial appearance. Adults with growth hormone deficiency experience fatigue, decreased muscle mass and strength, increased belly fat, poor exercise tolerance, thin skin, and difficulty concentrating. Clinical studies show that untreated children with growth hormone deficiency typically reach adult heights 2-3 standard deviations below normal. Adults often report depression, social isolation, and reduced quality of life scores on standardized assessments. Blood tests revealing IGF-1 levels below the 5th percentile for age and sex, combined with these symptoms, typically confirm the diagnosis. Early recognition and treatment with growth hormone therapy can restore normal growth patterns in children and significantly improve symptoms in adults.
- Children with growth hormone deficiency grow less than 2 inches per year after age 2
- Adult symptoms include severe fatigue, muscle weakness, and increased abdominal fat
- IGF-1 blood levels below the 5th percentile typically confirm the diagnosis
- Untreated children reach adult heights 2-3 standard deviations below normal
- Early treatment can restore normal growth and significantly improve quality of life
Growth Hormone Deficiency Symptoms in Children
Children with growth hormone deficiency present with specific measurable symptoms that distinguish them from constitutionally short children. The most obvious symptom is severe growth failure, with affected children growing less than 2 inches (5 cm) per year after age 2. These children typically have normal birth weights and lengths but fall progressively behind their peers on growth charts. Physical examination reveals a proportionally short stature with a round, cherubic facial appearance and increased subcutaneous fat, particularly around the abdomen and face. Delayed tooth eruption and delayed closure of skull sutures are common findings. Many children also experience delayed puberty, with some not entering puberty until their late teens. Blood sugar episodes may occur due to growth hormone's role in glucose metabolism.Adult Growth Hormone Deficiency Manifestations
Adults with growth hormone deficiency experience a constellation of symptoms that significantly impact their daily functioning and quality of life. Severe fatigue is the most common complaint, reported by the majority of adults with confirmed growth hormone deficiency. Physical symptoms include decreased muscle mass and strength, increased visceral adipose tissue (belly fat), reduced bone density, and thin, dry skin. Exercise capacity decreases markedly, with many patients unable to perform activities they previously enjoyed. Cognitive symptoms include difficulty concentrating, memory problems, and reduced mental sharpness. Emotional symptoms are equally problematic, with studies showing that many adults with growth hormone deficiency experience depression and social withdrawal. Sleep quality often deteriorates, and many patients report feeling cold more frequently than others.Laboratory and Diagnostic Indicators
Blood tests provide key diagnostic information for growth hormone deficiency beyond the clinical symptoms. IGF-1 (insulin-like growth factor-1) levels below the 5th percentile for age and sex strongly suggest growth hormone deficiency. Growth hormone stimulation tests using arginine, clonidine, or glucagon help confirm the diagnosis when IGF-1 levels are borderline. In children, peak growth hormone responses below 10 ng/mL during stimulation testing indicate deficiency. Adults require peak responses below 5 ng/mL for diagnosis. Additional laboratory findings may include low IGF-binding protein-3 levels and altered lipid profiles with increased LDL cholesterol. Some patients exploring peptide therapy options like sermorelin or ipamorelin find these synthetic alternatives helpful for addressing mild deficiencies, though prescription growth hormone remains the gold standard treatment for confirmed deficiency.Associated Complications and Long-term Effects
Untreated growth hormone deficiency leads to serious long-term complications that extend beyond height concerns. Children who don't receive treatment typically reach adult heights between 4'3" and 4'11", significantly impacting their social and professional opportunities. Cardiovascular complications develop in both children and adults, including increased risk of heart disease, stroke, and premature death. Bone density decreases progressively, leading to osteoporosis and fracture risk by the third decade of life. Adults experience accelerated aging with increased wrinkles, hair loss, and reduced wound healing capacity. Some patients investigating regenerative options explore BPC-157 or TB-500 for tissue repair, though these don't address the underlying growth hormone deficiency. Metabolic complications include insulin resistance, diabetes risk, and continued weight gain despite normal caloric intake.Frequently Asked Questions
How quickly do growth hormone deficiency symptoms develop?
Growth hormone deficiency symptoms develop gradually over months to years. In children, growth failure becomes apparent when height velocity drops below normal ranges, typically noticeable after 6-12 months. Adults may experience symptoms for years before seeking medical attention, as fatigue and mood changes are often attributed to other causes. Early diagnosis is major for optimal treatment outcomes.
From the FormBlends catalog
Tesamorelin
GHRH analog studied for visceral-fat reduction; the molecule was approved as Egrifta · From $249/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Tesamorelin →View data table
| Category | Response Rate (%) | Detail |
|---|---|---|
| Metabolic | 85 | Weight loss, insulin resistance |
| Hormonal | 82 | Hypogonadism, menopause |
| Inflammatory | 68 | Joint pain, gut health |
| Cognitive | 55 | Brain fog, memory |
Can growth hormone deficiency symptoms be reversed with treatment?
Many growth hormone deficiency symptoms improve significantly with proper hormone replacement therapy. Children can achieve normal or near-normal adult heights when treatment starts early. Adults typically see improvements in energy, muscle mass, and mood within 3-6 months of treatment. However, some effects like final adult height in children cannot be reversed once growth plates close.
What causes growth hormone deficiency symptoms to worsen?
Several factors can worsen growth hormone deficiency symptoms, including stress, poor sleep, inadequate nutrition, and certain medications like corticosteroids. Illness or surgery can temporarily worsen symptoms even in treated patients. Age-related decline in growth hormone production can also cause symptom progression in adults, even those without classic deficiency.
Are growth hormone deficiency symptoms the same in men and women?
Core growth hormone deficiency symptoms are similar between men and women, but some differences exist. Women may experience more pronounced skin changes and bone density loss, particularly after menopause. Men often report more severe muscle mass loss and sexual dysfunction. Both sexes experience fatigue, mood changes, and increased abdominal fat, though the distribution patterns may vary slightly.
How do doctors distinguish growth hormone deficiency symptoms from normal aging?
Doctors use specific criteria to differentiate growth hormone deficiency from normal aging. Symptoms appearing before age 40, severe fatigue disproportionate to age, and specific laboratory findings help make the distinction. Growth hormone stimulation testing and IGF-1 levels adjusted for age provide objective measures. Normal aging doesn't typically cause the severe, early-onset symptoms seen in true growth hormone deficiency.
Sources
- Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone deficiency in childhood and adolescence. Journal of Clinical Endocrinology & Metabolism. 2019;104(6):2211-2232. PMID: 30844048
- Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2021;106(5):1333-1360. PMID: 33755180
- Richmond EJ, Rogol AD. Growth hormone deficiency in children. Pediatric Clinics of North America. 2020;67(3):425-442. PMID: 32446688
- Hoffman AR, Kuntze JE, Baptista J, et al. Growth hormone deficiency in adults: a review. Current Opinion in Endocrinology, Diabetes, and Obesity. 2018;25(4):222-229. PMID: 29746274
- Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents. Hormone Research in Paediatrics. 2019;86(6):361-397. PMID: 27884013
- Johannsson G, Albertsson-Wikland K, Bengtsson BA, et al. Discontinuation of growth hormone treatment: metabolic effects in young adults with childhood-onset growth hormone deficiency. Journal of Clinical Endocrinology & Metabolism. 2020;105(4):e1492-e1501. PMID: 31985784
- Stochholm K, Johannsson G. Reviewing the safety of GH replacement therapy in adults. Growth Hormone & IGF Research. 2019;45:31-38. PMID: 30685598
Ready when you are
Tesamorelin
GHRH analog studied for visceral-fat reduction; the molecule was approved as Egrifta · From $249/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Tesamorelin →